HeinemannL, WoodworthJR. Pharmacokinetics and metabolism of insulin lispro. Drugs Today, 1998; 34,Suppl C:23–36.
2.
ClemensAH, ChangPH, MyersRW. The development of Biostator, a glucose controlled insulin infusion system (GCIIS)Horm Metab Res, 1977; Suppl 7:23–33.
3.
MudaliarSR, LindbergFA, JoyceM, BeerdsenP, StrangeP, LinA, HenryRR. Insulin aspart (B28 Asp-Insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care, 1999; 22:1501–1506.
4.
SkjaervoldNK, LyngO, SpigsetO, AadahlP. Pharmacology of intravenous insulin administration: implications for future closed-loop glycemic control by the intravenous/intravenous route. Diabetes Technol Ther, 2012; 14:23–29.
5.
MoghissiES, KorytkowskiMT, DeNardoM, EinhornD, HellmanR, HirschIB, InzucchiSE, Ismail-BeigiF, KirkmanMS, UmpierezGE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care, 2009; 32:1119–1131.
